FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313655316> ?p ?o ?g. }

• W4313655316 endingPage "6449" @default.
• W4313655316 startingPage "6438" @default.
• W4313655316 abstract "Colquhounia Root Tablets, prepared from Tripterygium, is effective for rheumatoid arthritis, diabetic nephropathy, and membranous nephropathy. However, the adverse reactions, such as liver injury, nausea, and vomiting, limit its application. This study aims to evaluate the advantages and risk of Colquhounia Root Tablets and its key active components in the treatment of rheumatoid arthritis, diabetic nephropathy, and membranous nephropathy and explore the potential mechanism in treating different diseases based on in vitro efficacy and toxicity assessment and biomolecular network analysis. First, the components of Colquhounia Root Tablets absorbed in blood were detected via ultra-performance liquid chromatography-quadrupole-time of flight mass spectrometry, and the influence of Colquhounia Root Tablets and its key components triptolide and celastrol on viability of human hepatocyte L02, human rheumatoid fibroblast-like synovial cell MH7 A, human renal tubular epithelial cell HK-2, and mouse podocyte MPC-5 was detected by cell counting kit 8(CCK8) assay. Then the expression of inflammatory cytokines of MH7 A and HK-2 cells was detected by enzyme-linked immunosorbent assay(ELISA). Moreover, the expression of nephrin and podocin in MPC-5 cells was measured by Western blot, and the expression of cytoskeletal protein by immunofluorence assay. Candidate targets of components from Colquhounia Root Tablets absorbed in blood were retrieved from TCMIP v2.0, and targets of the three diseases from GEO. The "disease-related genes-drug targets" network was constructed based on STRING, followed by pathway enrichment. Finally, molecular docking was performed by AutoDock Vina to explore the binding affinity of triptolide and celastrol with putative targets in the key signaling pathway. RESULTS:: showed that Colquhounia Root Tablets, triptolide, and celastrol can obviously reduce the levels of inflammatory cytokines in supernatant of MH7 A and HK-2 cells and enhance the expression of nephrin and podocin in MPC-5 cells. In addition, triptolide had the strongest toxicity to L02 cells, while Huobahuagen Tablets had the least toxicity to hepatocytes. Network analysis revealed that Colquhounia Root Tablets may intervene the three diseases through PI3 K/HIF1α/NOS signaling pathway. Both triptolide and celastrol had high binding affinities to corresponding targets in this signaling pathway. In conclusion, Colquhounia Root Tablets exerts similar effects on rheumatoid arthritis, diabetic nephropathy, and membranous nephropathy to triptolide and celastrol, but the toxicity was lower. PI3 K/HIF1α/NOS signaling pathway may be the common pathway of Colquhounia Root Tablets in the treatment of the three diseases." @default.
• W4313655316 created "2023-01-07" @default.
• W4313655316 creator A5026439831 @default.
• W4313655316 creator A5038383749 @default.
• W4313655316 creator A5047119468 @default.
• W4313655316 creator A5049410725 @default.
• W4313655316 creator A5050336469 @default.
• W4313655316 creator A5060359777 @default.
• W4313655316 creator A5067631353 @default.
• W4313655316 creator A5070539835 @default.
• W4313655316 creator A5074455515 @default.
• W4313655316 date "2022-12-01" @default.
• W4313655316 modified "2023-09-29" @default.
• W4313655316 title "[In vitro benefit-risk evaluation and network regulation mechanism of Colquhounia Root Tablets and its key material basis]." @default.
• W4313655316 doi "https://doi.org/10.19540/j.cnki.cjcmm.20221010.401" @default.
• W4313655316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36604890" @default.
• W4313655316 hasPublicationYear "2022" @default.
• W4313655316 type Work @default.
• W4313655316 citedByCount "0" @default.
• W4313655316 crossrefType "journal-article" @default.
• W4313655316 hasAuthorship W4313655316A5026439831 @default.
• W4313655316 hasAuthorship W4313655316A5038383749 @default.
• W4313655316 hasAuthorship W4313655316A5047119468 @default.
• W4313655316 hasAuthorship W4313655316A5049410725 @default.
• W4313655316 hasAuthorship W4313655316A5050336469 @default.
• W4313655316 hasAuthorship W4313655316A5060359777 @default.
• W4313655316 hasAuthorship W4313655316A5067631353 @default.
• W4313655316 hasAuthorship W4313655316A5070539835 @default.
• W4313655316 hasAuthorship W4313655316A5074455515 @default.
• W4313655316 hasConcept C185592680 @default.
• W4313655316 hasConcept C190283241 @default.
• W4313655316 hasConcept C202751555 @default.
• W4313655316 hasConcept C2781164371 @default.
• W4313655316 hasConcept C53227056 @default.
• W4313655316 hasConcept C55493867 @default.
• W4313655316 hasConcept C71924100 @default.
• W4313655316 hasConcept C98274493 @default.
• W4313655316 hasConceptScore W4313655316C185592680 @default.
• W4313655316 hasConceptScore W4313655316C190283241 @default.
• W4313655316 hasConceptScore W4313655316C202751555 @default.
• W4313655316 hasConceptScore W4313655316C2781164371 @default.
• W4313655316 hasConceptScore W4313655316C53227056 @default.
• W4313655316 hasConceptScore W4313655316C55493867 @default.
• W4313655316 hasConceptScore W4313655316C71924100 @default.
• W4313655316 hasConceptScore W4313655316C98274493 @default.
• W4313655316 hasIssue "23" @default.
• W4313655316 hasLocation W43136553161 @default.
• W4313655316 hasOpenAccess W4313655316 @default.
• W4313655316 hasPrimaryLocation W43136553161 @default.
• W4313655316 hasRelatedWork W2023848967 @default.
• W4313655316 hasRelatedWork W2393287359 @default.
• W4313655316 hasRelatedWork W2542878138 @default.
• W4313655316 hasRelatedWork W2626451148 @default.
• W4313655316 hasRelatedWork W2748952813 @default.
• W4313655316 hasRelatedWork W2777191117 @default.
• W4313655316 hasRelatedWork W2779270276 @default.
• W4313655316 hasRelatedWork W2888370728 @default.
• W4313655316 hasRelatedWork W2899084033 @default.
• W4313655316 hasRelatedWork W3005404103 @default.
• W4313655316 hasVolume "47" @default.
• W4313655316 isParatext "false" @default.
• W4313655316 isRetracted "false" @default.
• W4313655316 workType "article" @default.